Nuvectis Pharma, Inc. NVCT Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$6.05M-13.5% | -$7.31M-17.1% | -$7.46M-79.7% | -$6.33M-43.0% | -$5.33M-27.8% | ||
| $1.85M+35.2% | $1.48M+29.4% | $1.46M+25.7% | $1.73M+37.2% | $1.37M+5.6% | ||
| -$1.58M-420% | $0— | $1.46M— | $1.99M— | $494K+149% | ||
| -$79K-416% | —— | —— | -$863K-390% | $25K-64.8% | ||
| $193K-8.1% | —— | —— | —— | $210K+9.9% | ||
| -$6.51M-56.0% | -$3.97M-61.2% | -$4.49M-86.9% | -$3.37M-11.5% | -$4.17M+4.2% | ||
| $0— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | —— | ||
| $7K-100.0% | $166K-95.7% | $13.14M+802% | $296K-82.3% | $15.51M+230% | ||
| -$6.5M-157% | —— | $8.65M+1,013% | —— | $11.33M+3,252% | ||
| -$460K+11.4% | $1.91M+7.1% | -$83K— | $44K— | -$519K-47.9% | ||
| $193K-8.1% | —— | —— | —— | $210K+9.9% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $300K— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Nuvectis Pharma, Inc. generate?
- Nuvectis Pharma, Inc. (NVCT) generated -$18.3M in operating cash flow over the trailing twelve months.
- Where does Nuvectis Pharma, Inc.'s cash flow data come from?
- Every line is extracted from Nuvectis Pharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.